Talk to our breast care nurses
0808 800 6000
The Endocrinology team aims to understand how and why some patients’ cancers are resistant and others aren't.
Patients with triple negative breast cancer have limited treatment options because their breast tumours lack the receptors which targeted therapies like tamoxifen and Herceptin act against.
Stay in touch
We’d love to keep in touch about news, events and how you can get involved. To hear from us, enter your email address below.
Connect with us
